Who are T-Cypher Bio's investors?

T-Cypher Bio's investors include Future Planet Capital, LifeArc Ventures, Oxford Science Enterprises, Perivoli Innovations.

T-Cypher Bio

4 known investors

Find your way into T-Cypher Bio

T-Cypher Bio develops drugs with curative potential, focusing on antibody development, T cell biology, and TCR discovery. The company applies immunology and AI-driven approaches in the biotech sector.

AI & Machine Learning Biotech Deep Tech

Investors · 4

Future Planet Capitallisted by Future Planet CapitalLondon

How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us

LifeArc Ventureslisted by LifeArc VenturesLondon

How we know: LifeArc Ventures's portfolio page · Not right? Tell us

Oxford Science Enterpriseslisted by Oxford Science EnterprisesOxford · $63.5K – $31.8M

How we know: Oxford Science Enterprises's portfolio page · Not right? Tell us

Perivoli Innovationslisted by Perivoli InnovationsSt. Helier

In the news

About Us - T-Cypher Biotcypherbio.com

Frequently asked questions

What does T-Cypher Bio do?: T-Cypher Bio develops drugs with curative potential, focusing on antibody development, T cell biology, and TCR discovery. The company applies immunology and AI-driven approaches in the biotech sector.
Who are T-Cypher Bio's investors?: T-Cypher Bio's investors include Future Planet Capital, LifeArc Ventures, Oxford Science Enterprises, Perivoli Innovations.